Clinical trial Recruiting at 1 site Observational Ages 18 to 50 Women only

Monitoring glucose levels in women after gestational diabetes

Official title: Early Investigation of Glucose Monitoring After Gestational Diabetes (ENGAGED): Utility and Acceptability of Continuous Glucose Monitoring in the Early Postpartum Period After Gestational Diabetes Mellitus

Run by Ohio State University · NCT06184373 · Data updated 2026-11-12

This study is testing if wearing a continuous glucose monitor can help women who had gestational diabetes keep track of their blood sugar levels after giving birth.

More Gestational Diabetes trials

Quick facts

Study typeObservational
Ages18 Years to 50 Years
SexWomen only
Enrollment20 (estimated)
SponsorOhio State University
Academic / other
Locations1 site (Columbus, Ohio)
StatusRecruiting
StartedJune 6, 2025
Main results expectedMay 30, 2027
Study endsMay 30, 2027
Registry record updatedOctober 16, 2026
Trial IDNCT06184373 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are postpartum women who have had a recent pregnancy affected by gestational diabetes.

Probably not a fit

Patients with pregestational diabetes or those using diabetes medications immediately after delivery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the use of continuous glucose monitors (CGM) in postpartum women who have experienced gestational diabetes (GDM). Participants will wear a CGM device at 6-8 weeks postpartum to track their glucose levels and will complete surveys regarding their quality of life during this period. The goal is to assess the acceptability and feasibility of CGM as a screening tool for ongoing dysglycemia in women with a history of GDM, as traditional follow-up methods have low adherence rates. Data collected may inform future studies on the effectiveness of CGM in this population.

Why it matters

Potential benefit: If successful, this approach could improve postpartum glucose monitoring and follow-up care for women with a history of gestational diabetes.

How similar studies have gone: While the use of CGM in gestational diabetes is not extensively studied, similar approaches in diabetes management have shown promise, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women with a viable singleton intrauterine pregnancy
* Able to understand the study, and having understood, provide written informed consent in English
* Recent pregnancy affected by gestational diabetes

Exclusion Criteria:

* Pregestational Diabetes (Type I or Type II)
* Continued use of diabetes medications (including metformin and insulin) immediately after delivery
* Preterm delivery (\< 37 weeks gestation)
* Twin or higher order gestation
* No access to a smartphone
* Unable or unwilling to wear CGM or return for follow up at postpartum mother-infant dyad clinic
* Participation in this trial in a prior pregnancy
* History of skin allergy to adhesive products or CGM

Where it's running

  • Ohio State University Medical Center
    Columbus, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.